Paloma Partners’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Paloma Partners's AMGN Position: Q4 2024 in Review
Paloma Partners sold out of Amgen (AMGN) in Q4 2024, closing a stake of 1,997 shares — an estimated $643K sold.
Paloma Partners first reported a position in AMGN in Q2 2013 and held it in 36 quarters. The position peaked at $36.2M in Q3 2018. 2,855 funds tracked by Wall St. Rank hold AMGN as of Q4 2024.
- Paloma Partners reported no remaining Amgen position as of Q4 2024 after selling out during the quarter.
- Paloma Partners sold 1,997 Amgen shares in Q4 2024, an estimated $643K.
- Paloma Partners first reported a position in Amgen in Q2 2013 and held it in 36 quarters.
- Paloma Partners's Amgen position peaked at $36.2M in Q3 2018.
- 2,855 funds tracked by Wall St. Rank held Amgen as of Q4 2024.
Based on Paloma Partners's 13F filing for Q4 2024, filed 14 Feb 2025.